While tests of fatiguability were not conducted for more specific characterization of ocular symptoms, he had significant improvement in eye motility over time without the use of acetylcholinesterase inhibitors, steroids, plasmapheresis, or other standard therapies for MG. The gene discussed is ACHE; the disease is myasthenia gravis.